X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-17 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $95.12 | -4,000 | 543,446 | -1% | -$380,480 | |||||
2024-04-15 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $15.67 | -10,000 | 129,644 | -7% | -$156,700 | ||||||
| D | 2024-04-02 | MOVE | Movano Inc. | Caballero Ruben | Dir | P - Purchase | $0.00 | +22,000 | 80,200 | +38% | +$0 | |||||
| D | 2024-04-10 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $95.09 | -12,000 | 543,446 | -2% | -$1,141,080 | |||||
| DM | 2024-04-08 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.35 | -19,900 | 51,012 | -28% | -$1,798,002 | |||||
2024-04-08 | MDT | Medtronic Plc | Marinaro Michael | EVP, Pres, Surgical OU | S - Sale | $83.14 | -854 | 27,925 | -3% | -$71,002 | ||||||
| DM | 2024-04-03 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $80.21 | -10,000 | 51,012 | -16% | -$802,084 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Cogan Jeremy | CFO | P - Purchase | $0.00 | +45,000 | 780,649 | +6% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Cullinan Brian | Dir | P - Purchase | $0.00 | +44,000 | 260,070 | +20% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Fairbairn Emily | Dir | P - Purchase | $0.00 | +4,690,000 | 5,916,999 | +382% | +$0 | |||||
| D | 2024-04-02 | MOVE | Movano Inc. | Mastrototaro John | CEO | P - Purchase | $0.00 | +176,500 | 291,642 | +153% | +$0 | |||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $41.34 | -2,218 | 23,422 | -9% | -$91,694 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $41.34 | -5,175 | 62,953 | -8% | -$213,937 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $41.34 | -2,218 | 50,924 | -4% | -$91,694 | ||||||
2024-04-01 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $41.34 | -18,980 | 152,790 | -11% | -$784,645 | ||||||
2024-04-01 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $17.65 | -4,000 | 65,843 | -6% | -$70,600 | ||||||
| D | 2024-04-01 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $74.01 | -15,000 | 23,299 | -39% | -$1,110,150 | |||||
2024-03-27 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $17.99 | -454 | 319,682 | 0% | -$8,167 | ||||||
2024-03-27 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $17.99 | -515 | 139,644 | 0% | -$9,265 | ||||||
2024-03-27 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $17.99 | -395 | 159,145 | 0% | -$7,106 | ||||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Zaderej Karen L. | CEO | S - Sale+OE | $7.68 | -39,280 | 1,143,788 | -3% | -$301,670 | |||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Devinney Erick Wayne | Chief Innovation Officer | S - Sale+OE | $7.68 | -4,578 | 177,474 | -3% | -$35,159 | |||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Scopelianos Angelo | Chief R, D Officer | S - Sale+OE | $7.68 | -6,881 | 57,994 | -11% | -$52,846 | |||||
| D | 2024-03-21 | AXGN | Axogen, Inc. | Donovan Michael Patrick | VP Operations | S - Sale+OE | $7.68 | -6,033 | 54,250 | -10% | -$46,333 | |||||
2024-03-21 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $17.83 | -520 | 127,614 | 0% | -$9,272 | ||||||
2024-03-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $2.13 | -2,391 | 242,510 | -1% | -$5,093 | ||||||
| M | 2024-03-12 | BLFS | Biolife Solutions Inc | Duross Amy | Dir | S - Sale | $16.92 | -11,200 | 29,443 | -28% | -$189,541 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $16.64 | -7,508 | 140,159 | -5% | -$124,962 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $16.64 | -6,834 | 320,136 | -2% | -$113,701 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | S - Sale | $16.64 | -3,804 | 65,998 | -5% | -$63,315 | |||||
2024-03-12 | BLFS | Biolife Solutions Inc | De Greef Roderick | Pres, CEO | S - Sale | $16.60 | -7,249 | 461,854 | -2% | -$120,333 | ||||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $16.64 | -7,610 | 128,134 | -6% | -$126,622 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $16.65 | -5,496 | 159,540 | -3% | -$91,495 | |||||
| M | 2024-03-11 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $16.65 | -4,630 | 69,843 | -6% | -$77,079 | |||||
| D | 2024-03-08 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $87.80 | -1,417 | 51,012 | -3% | -$124,413 | |||||
2024-03-08 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale | $87.63 | -1,903 | 23,299 | -8% | -$166,760 | ||||||
2024-03-07 | AXGN | Axogen, Inc. | Donovan Michael Patrick | VP Operations | S - Sale | $8.81 | -36,310 | 35,708 | -50% | -$319,891 | ||||||
2024-03-07 | AXGN | Axogen, Inc. | Freitag Gregory Gene | Dir | S - Sale | $9.00 | -25,000 | 271,594 | -8% | -$225,000 | ||||||
| D | 2024-03-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $82.99 | -10,000 | 52,329 | -16% | -$829,892 | |||||
| D | 2024-03-04 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $82.80 | -15,000 | 25,202 | -37% | -$1,242,000 | |||||
2024-03-01 | TMDX | Transmedics Group, Inc. | Tobin James R | Dir | S - Sale | $83.63 | -13,380 | 221,404 | -6% | -$1,118,955 | ||||||
2024-03-01 | ELMD | Electromed, Inc. | Cunniff James L. | CEO, Pres | P - Purchase | $15.25 | +9,000 | 10,000 | +900% | +$137,250 | ||||||
2024-03-01 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $3.15 | -1,584 | 322,877 | 0% | -$4,990 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $17.35 | -58 | 41,806 | 0% | -$1,006 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $17.35 | -97 | 64,823 | 0% | -$1,683 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | S - Sale | $17.35 | -131 | 58,120 | 0% | -$2,273 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $17.35 | -111 | 115,688 | 0% | -$1,926 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $17.35 | -101 | 275,214 | 0% | -$1,752 | ||||||
2024-02-21 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $17.35 | -87 | 123,940 | 0% | -$1,509 | ||||||
| M | 2024-02-21 | SVVC | Firsthand Technology Value Fund, Inc. | Star Equity Fund, LP | 10% | P - Purchase | $0.28 | +165,952 | 1,985,724 | +9% | +$46,566 | |||||
| D | 2024-02-21 | MDT | Medtronic Plc | Salmon Sean | EVP, Pres Cardiovascular | S - Sale+OE | $85.13 | -30,695 | 48,289 | -39% | -$2,613,055 | |||||
| DM | 2024-02-16 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.00 | -3,108 | 40,202 | -7% | -$279,720 | |||||
2024-02-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +1,078 | 14,404,916 | 0% | +$1,089 | ||||||
2024-02-15 | OM | Outset Medical, Inc. | Williamson Steven S. | Chief Commercial Officer | S - Sale | $3.57 | -2,500 | 320,347 | -1% | -$8,925 | ||||||
2024-02-15 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $3.57 | -5,320 | 841,861 | -1% | -$18,992 | ||||||
2024-02-15 | OM | Outset Medical, Inc. | Racine Jean-Olivier | CTO | S - Sale | $3.57 | -1,866 | 271,830 | -1% | -$6,662 | ||||||
2024-02-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $3.57 | -617 | 243,100 | 0% | -$2,203 | ||||||
2024-02-15 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $3.57 | -3,341 | 245,046 | -1% | -$11,927 | ||||||
| DM | 2024-02-14 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.02 | -3,826 | 40,202 | -9% | -$344,432 | |||||
2024-02-15 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $3.57 | -4,403 | 312,594 | -1% | -$15,719 | ||||||
2024-02-16 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.11 | -3,230 | 96,526 | -3% | -$3,585 | ||||||
| AM | 2023-11-30 | HSDT | Helius Medical Technologies, Inc. | Andreeff Dane | Pres, CEO, 10% | P - Purchase | $6.41 | +1,284 | 25,586 | +5% | +$8,229 | |||||
| M | 2024-02-08 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +2,190 | 14,403,838 | 0% | +$2,212 | |||||
| D | 2024-02-07 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.09 | -736 | 40,202 | -2% | -$66,306 | |||||
2024-02-06 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale | $86.38 | -7,157 | 8,350 | -46% | -$618,209 | ||||||
| M | 2024-02-05 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +1,995 | 14,401,648 | 0% | +$2,015 | |||||
2024-01-31 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +100 | 14,399,653 | 0% | +$101 | ||||||
| D | 2024-02-01 | TMDX | Transmedics Group, Inc. | Gordon Stephen | CFO | S - Sale+OE | $85.45 | -15,000 | 13,075 | -53% | -$1,281,750 | |||||
2024-01-25 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $48.30 | -397 | 25,640 | -2% | -$19,175 | ||||||
2024-01-25 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $48.30 | -832 | 43,142 | -2% | -$40,186 | ||||||
2024-01-25 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $48.30 | -2,527 | 171,770 | -1% | -$122,054 | ||||||
2024-01-23 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +834 | 14,399,553 | 0% | +$842 | ||||||
2024-01-23 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $17.11 | -336 | 41,864 | -1% | -$5,749 | ||||||
| D | 2024-01-23 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.09 | -2,330 | 40,202 | -5% | -$209,910 | |||||
2024-01-19 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $16.76 | -1,198 | 124,027 | -1% | -$20,078 | ||||||
2024-01-19 | BLFS | Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | S - Sale | $16.76 | -1,776 | 58,251 | -3% | -$29,766 | ||||||
2024-01-19 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $16.76 | -1,450 | 275,315 | -1% | -$24,302 | ||||||
2024-01-19 | BLFS | Biolife Solutions Inc | De Greef Roderick | Pres, CEO | S - Sale | $16.76 | -2,642 | 439,897 | -1% | -$44,280 | ||||||
2024-01-19 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $16.76 | -2,419 | 64,920 | -4% | -$40,542 | ||||||
2024-01-19 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $16.76 | -862 | 42,200 | -2% | -$14,447 | ||||||
2024-01-19 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $16.76 | -1,232 | 115,799 | -1% | -$20,648 | ||||||
| D | 2023-12-28 | NRX | Neuraxis, Inc | Hannasch Brian | 10% | S - Sale+OE | $2.61 | -76 | 532,901 | 0% | -$198 | |||||
2024-01-22 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +7,620 | 14,398,719 | 0% | +$7,696 | ||||||
| M | 2024-01-18 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +1,076 | 14,391,099 | 0% | +$1,087 | |||||
| D | 2024-01-16 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $80.41 | -10,000 | 40,202 | -20% | -$804,088 | |||||
2024-01-16 | OM | Outset Medical, Inc. | Williamson Steven S. | Chief Commercial Officer | S - Sale | $4.29 | -996 | 322,847 | 0% | -$4,273 | ||||||
2024-01-16 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $4.29 | -8,126 | 847,181 | -1% | -$34,861 | ||||||
2024-01-16 | OM | Outset Medical, Inc. | Racine Jean-Olivier | CTO | S - Sale | $4.29 | -723 | 273,696 | 0% | -$3,102 | ||||||
2024-01-16 | OM | Outset Medical, Inc. | Porter Stacey L. | Chief People Officer | S - Sale | $4.29 | -768 | 61,448 | -1% | -$3,295 | ||||||
2024-01-16 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $429.00 | -678 | 243,717 | 0% | -$290,862 | ||||||
2024-01-16 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $4.29 | -1,480 | 248,387 | -1% | -$6,349 | ||||||
2024-01-16 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $4.29 | -1,726 | 316,997 | -1% | -$7,405 | ||||||
2024-01-12 | ECOR | Electrocore, Inc. | Posner Brian M | CFO | P - Purchase | $0.00 | +16,000 | 22,437 | +249% | +$0 | ||||||
2024-01-16 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.01 | +13,067 | 14,390,023 | 0% | +$13,198 | ||||||
2024-01-08 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.08 | +6,731 | 14,376,956 | 0% | +$7,269 | ||||||
2024-01-08 | OM | Outset Medical, Inc. | Williamson Steven S. | Chief Commercial Officer | S - Sale | $5.49 | -7,055 | 105,939 | -6% | -$38,732 | ||||||
2024-01-08 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $5.49 | -14,188 | 397,869 | -3% | -$77,892 | ||||||
2024-01-08 | OM | Outset Medical, Inc. | Racine Jean-Olivier | CTO | S - Sale | $5.49 | -3,905 | 73,781 | -5% | -$21,438 | ||||||
2024-01-08 | OM | Outset Medical, Inc. | Porter Stacey L. | Chief People Officer | S - Sale | $5.49 | -4,766 | 58,630 | -8% | -$26,165 | ||||||
2024-01-08 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $5.49 | -7,344 | 48,807 | -13% | -$40,319 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |